Basic Principles & Clinical Relevance of the IAS-USA 2022 Drug Resistance Mutations in HIV-1

Presenters: Francesca Ceccherini Silberstein, PhD, Annemarie M. Wensing, MD, PhD
Moderator: Douglas D. Richman, MD
January 31, 2024
This webinar is useful for those who wish to utilize the IAS-USA 2022 Update of the Drug Resistance Mutations in HIV-1 for the management of antiretroviral therapy (ART) in their patients with HIV. This webinar will review the principles of HIV drug resistance mutations and summarize what is currently known about resistance to antiretroviral drugs and products, including new and long-acting medications. The webinar includes an overview of how to read the IAS-USA mutation charts and explains the relevance of this information in clinical practice.